Regis CEO Felipe Athayde resigns; Matt Doctor named Interim CEO

REGIS CORP

Felipe Athayde resigns as President and CEO, effective March 19, 2022; remains on Board until then.
Matthew Doctor appointed Interim CEO effective Dec 23, 2021; base salary raised to $550,000, target 100% incentive, plus $100,000 acceptance bonus.
Jim Lain appointed COO effective Dec 23, 2021; base salary raised to $425,000, target annual incentive remains at 70%.
Board commences search for permanent CEO, considering internal and external candidates.
Michael Ferranti promoted to Executive Vice President and Chief People Officer.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Felipe A. Athayde

President and Chief Executive Officer

RGS · REGIS CORP

Effective: 2022-03-19
Successor: Matthew Doctor
Filed: December 23, 2021, 6:59 PM ET

On December 19, 2021, Felipe A. Athayde, the President and Chief Executive Officer and a member of the Board of Directors (the "Board") of Regis Corporation (the "Company") notified the Board that he would resign his positions and his employment effective March 19, 2022.

Appointed (interim)

Matthew Doctor

Interim Chief Executive Officer

RGS · REGIS CORP

Effective: 2021-12-23
Filed: December 23, 2021, 6:59 PM ET

the Board appointed Matthew Doctor, the Company's Executive Vice President and Chief Strategy Officer, to serve as Interim Chief Executive Officer effective December 23, 2021

Appointed

Jim Lain

Chief Operating Officer

RGS · REGIS CORP

Effective: 2021-12-23
Filed: December 23, 2021, 6:59 PM ET

the Board appointed Jim Lain, the Company's President, Franchise Operations, who functions as the Company's principal operating officer, to the position of Chief Operating Officer of the Company, also effective December 23, 2021

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Felipe A. Athayde resigned as President and Chief Executive Officer at REGIS CORP.

Action: resigned
Role: President and Chief Executive Officer

Exact text from the filing

On December 19, 2021, Felipe A. Athayde, the President and Chief Executive Officer and a member of the Board of Directors (the "Board") of Regis Corporation (the "Company") notified the Board that he would resign his positions and his employment effective March 19, 2022.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Matthew Doctor was appointed as Interim Chief Executive Officer at REGIS CORP.

Action: appointed
Role: Interim Chief Executive Officer

Exact text from the filing

the Board appointed Matthew Doctor, the Company's Executive Vice President and Chief Strategy Officer, to serve as Interim Chief Executive Officer effective December 23, 2021

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jim Lain was appointed as Chief Operating Officer at REGIS CORP.

Action: appointed
Role: Chief Operating Officer

Exact text from the filing

the Board appointed Jim Lain, the Company's President, Franchise Operations, who functions as the Company's principal operating officer, to the position of Chief Operating Officer of the Company, also effective December 23, 2021

View on SEC.gov

REGIS CORP filing history →

Source: SEC EDGAR

accession 0000716643-21-000096

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.